[The role of disease-modifying antirheumatic drugs (DMARDs) in the therapy of rheumatoid arthritis].
The destructive process seen on the cartilage and on the sub-chondral bone of patients with rheumatoid arthritis, which is a chronic inflammatory disease of unknown aetiology, is in part unavoidable. The aim of the treatment is not only to reduce articular inflammation and/or to relieve pain, but also to prevent or delay articular damage and to improve quality of life of rheumatoid patients. The use of new available drugs, with a modern therapeutic approach, seems to be apt to improve considerably the outcome in rheumatoid patients.
Cervini
C
C
Salaffi
F
F
Peroni
M
M
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D013256:Steroids; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D013256:Steroids
Ruolo dei "disease modifying antirheumatic drugs" (DMARDs) nella terapia dell'artrite reumatoide.